Therefore, targeting IL-17 alone or in combination with IL-6 may be an approach to treat COVID-19 against “cytokine storm.” However, the specific relations between IL-6 and IL-17 in COVID-19 patients need to be further studies. The gene discussed is IL17A; the disease is COVID-19.